Research map: Polymorphisms in the Bordetella pertussis virulence factor SphB1 and altered antigen expression of clinical isolates before and after acellular pertussis vaccination in Finland

Back to the article

Papers in this map

  1. Bordetella pertussisStrains with Increased Toxin Production Associated with Pertussis Resurgence · Frits R. Mooi · 2009 · 361 citations · Cited by this paper
  2. Protective immunity of lectin-adjuvanted intraperitoneal injection vaccine against Aeromonas veronii infection in Oreochromis niloticus · 2026 · Related
  3. Global Population Structure and Evolution of Bordetella pertussis and Their Relationship with Vaccination · Marieke J Bart · 2014 · 324 citations · Cited by this paper
  4. A systematic meta-analytic comparative evaluation of seasonal influenza vaccine effectiveness from test-negative design studies in the Northern Hemisphere pre/post COVID-19 pandemic · 2026 · Related
  5. Pertussis resurgence: waning immunity and pathogen adaptation – two sides of the same coin · Frits R. Mooi · 2013 · 318 citations · Cited by this paper
  6. Strategies and lessons learned from a type 1 circulating vaccine-derived poliovirus (cVDPV) outbreak affecting adult population: Madagascar, 2020–2023 · 2026 · Related
  7. Bordetella pertussis and vaccination: The persistence of a genetically monomorphic pathogen · Frits R. Mooi · 2009 · 212 citations · Cited by this paper
  8. Beyond coverage: Timeliness of routine childhood vaccination and its determinants in rural northern Ghana · 2026 · Related
  9. First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin · Valérie Bouchez · 2009 · 174 citations · Cited by this paper
  10. Using tree-based scan statistics to assess vaccines for possible associations with Guillain-Barré syndrome in the Vaccine Safety Datalink · 2026 · Related
  11. Interaction of Calcium with Bordetella pertussis Adenylate Cyclase Toxin · Thierry Rose · 1995 · 171 citations · Cited by this paper
  12. Beyond zero-dose: routine immunization retention gaps in the Dominican Republic, 2019–2025 · 2026 · Related
  13. Subtilisin‐like autotransporter serves as maturation protease in a bacterial secretion pathway · Loïc Coutte · 2001 · 151 citations · Cited by this paper
  14. Ethical challenges in outbreak trial design: from Ebola to Nipah · 2026 · Related
  15. Variation in the Bordetella pertussis Virulence Factors Pertussis Toxin and Pertactin in Vaccine Strains and Clinical Isolates in Finland · Frits R. Mooi · 1999 · 124 citations · Cited by this paper
  16. Intersection of vaccination, health literacy, education, and communication in South America: A scientometric mapping · 2026 · Related
  17. Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015 · Alex‐Mikael Barkoff · 2019 · 102 citations · Cited by this paper
  18. Efficacy and safety of a non-adjuvanted Bordetella bronchiseptica extract vaccine with recombinant pertactin administered subcutaneously to dogs · 2026 · Related
  19. Pertactin-Deficient Bordetella pertussis , Vaccine-Driven Evolution, and Reemergence of Pertussis · Longhuan Ma · 2021 · 97 citations · Cited by this paper
  20. mRNA-LNP hepatitis C vaccine encoding p7 elicits improved humoral immunogenicity · 2026 · Related
  21. Pathogenicity and virulence of Bordetella pertussis and its adaptation to its strictly human host · Thomas Belcher · 2021 · 85 citations · Cited by this paper
  22. Global spatial dynamics and vaccine-induced fitness changes of Bordetella pertussis · Noémie Lefrancq · 2022 · 68 citations · Cited by this paper
  23. New Data on Vaccine Antigen Deficient Bordetella pertussis Isolates · Valérie Bouchez · 2015 · 53 citations · Cited by this paper
  24. Surveillance of Circulating Bordetella pertussis Strains in Europe during 1998 to 2015 · Alex‐Mikael Barkoff · 2018 · 44 citations · Cited by this paper
  25. Bordetella pertussis Isolates in Finland: Serotype and Fimbrial Expression · Eriikka Heikkinen · 2008 · 37 citations · Cited by this paper
  26. Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom · Pauline Versteegen · 2021 · 36 citations · Cited by this paper
  27. Molecular Epidemiology of Bordetella pertussis · Alex‐Mikael Barkoff · 2019 · 33 citations · Cited by this paper
  28. Macrolide-resistant Bordetella pertussis strain identified during an ongoing epidemic, Finland, January to October 2024 · Milja Miettinen · 2024 · 28 citations · Cited by this paper
  29. Biological differences between FIM2 and FIM3 fimbriae of Bordetella pertussis: not just the serotype · Soraya Matczak · 2023 · 12 citations · Cited by this paper
  30. Bordetella filamentous hemagglutinin and adenylate cyclase toxin interactions on the bacterial surface are consistent with FhaB-mediated delivery of ACT to phagocytic cells · Zachary M. Nash · 2024 · 12 citations · Cited by this paper
  31. Bordetella pertussis isolates in Finland after acellular vaccination: serotype change and biofilm formation · Vili Niinikoski · 2024 · 9 citations · Cited by this paper
  32. Evolutionary dynamics and global spread of macrolide-resistant Bordetella pertussis during the post-pandemic pertussis resurgence · Haodong Zhang · 2026 · 6 citations · Cited by this paper
  33. Fim3-dependent autoagglutination of Bordetella pertussis · Nao Otsuka · 2023 · 5 citations · Cited by this paper
  34. Alterations in the expression of Bordetella pertussis antigens in relation to the use of acellular pertussis vaccine in Finland · Vili Niinikoski · 2025 · 4 citations · Cited by this paper

Source: OpenAlex (CC0)